Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2021-01-20 Capital/Financing Update
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Results of SPP 2 pages 192.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 21 January 2021 regarding the results of a Share Purchase Plan (SPP) by Medical Developments International Limited. It details the amount raised, issue price, number of shares to be issued, and timing of share issuance and trading commencement. The content focuses on capital raising activity and share issuance, not on financial results, management changes, or regulatory certifications. The document length is 3318 characters, which is relatively short and typical for an announcement rather than a full report. There is no indication that this is a full financial report, audit, or earnings release. The primary subject is the update on a financing event (share purchase plan results). Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-01-20 English
Proposed issue of Securities - MVP 5 pages 27.4KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Medical Developments International Limited. It details the number and type of securities to be issued, the issue price, the proposed issue date, and compliance with ASX listing rules. There is no financial performance data, management discussion, or audit information. The document is focused on informing about a capital raising activity through a placement or other issue of securities. This fits the definition of a Capital/Financing Update (CAP). The document length and content confirm it is not merely a brief notice or a report publication announcement but a substantive announcement about financing activity.
2020-12-23 English
Cleansing Notice 2 pages 147.7KB
Capital/Financing Update Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) regarding the issuance of fully paid ordinary shares as part of an institutional placement. It states the shares were issued without disclosure under Part 6D.2 of the Act and confirms compliance with relevant disclosure obligations. The document is short (3438 characters) and is a formal announcement about a share placement, not a full financial report or detailed analysis. It does not contain financial statements or management discussion but is an update on capital raising activity. Therefore, it fits the category of Capital/Financing Update (CAP).
2020-12-17 English
Share Purchase Plan 17 pages 691.6KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 18 December 2020 regarding a Share Purchase Plan (SPP) offer opening for Medical Developments International Limited (MVP). It details the terms, conditions, and timetable of the SPP, including the issue price, eligibility, and participation instructions. The document includes a Share Purchase Plan Booklet with terms and conditions, a chairman's letter inviting shareholders to participate, and legal disclaimers. The content focuses on fundraising through a share issue and provides detailed information about the capital raising event. There are no financial statements or quarterly results presented, nor is this a regulatory filing or a report publication announcement. The document is clearly an update on capital raising activities and share issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-12-17 English
Appendix 2A 14 pages 249.2KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes details about the entity, the type of securities being quoted, references to previous announcements (Appendix 3B), and information about share issuance and plans. This type of document is a regulatory announcement related to capital markets activity, specifically the listing or quotation of new securities. It is not a financial report, earnings release, or management discussion. It is also not a proxy, AGM material, or legal proceeding. The document is a formal regulatory filing to the exchange about securities quotation, which fits the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-12-16 English
Update - Proposed issue of Securities - MVP 9 pages 37.9KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Proposed issue of securities' and contains detailed information about a securities purchase plan (SPP) and a placement by Medical Developments International Limited. It includes specifics such as minimum and maximum acceptance values, offer price, number of securities to be issued, timetable, fees, and approvals related to the securities issuance. There is no indication that this is a full financial report, earnings release, or management discussion. The content clearly relates to an update on capital raising activities and issuance of new shares. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial (over 12,000 characters), indicating it is not a brief announcement or a report publication announcement. Hence, the classification is CAP with high confidence.
2020-12-16 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.